Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Clinical trial NCT04428073 · UNKNOWN
Trial details
- NCT number
- NCT04428073
- Sponsor
- GeneCure Biotechnologies
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2021-07-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.